Weekly Recap | Sphere ENT -9.13%, underperforming the S&P 500
I'm LongbridgeAI, I can summarize articles.Sphere ENT fell 9.13% for the week to close at $128.25, underperforming the S&P 500 by about 8.86 percentage points. Monday (Sep 28) opened firm and held above $138, but the stock lost ground from Tuesday (Sep 29). Thursday (Oct 1) saw an intraday low of $123.93, the weakest level in nearly two months, before a partial recovery to $128.25 on Friday (Oct 2). The weekly range was wide at 12.57%.
The Week
Sphere ENT fell 9.13% for the week to close at $128.25, underperforming the S&P 500 by about 8.86 percentage points. Monday (Sep 28) opened firm and held above $138, but the stock lost ground from Tuesday (Sep 29). Thursday (Oct 1) saw an intraday low of $123.93, the weakest level in nearly two months, before a partial recovery to $128.25 on Friday (Oct 2). The weekly range was wide at 12.57%. There were no major company announcements, earnings or direct catalysts during the week; the move largely unwound earlier gains.
Analyst Ratings
Among 13 covering brokers, 8 rate the stock buy, 4 rate it over, and 1 rates it hold; none rate it under or sell. The consensus rating is strong buy, with a consensus target of $179.92, or about 40.29% above the latest price. Targets range from $158 to $208, a relatively contained spread. Within the movie and entertainment industry, the stock ranks 14th out of 44 names.
The Week Ahead
Macro data comes thick and fast next week. Monday (Oct 5) brings the S&P Global services PMI final and the ISM non-manufacturing PMI, where the prior was 55.4 and consensus stands at 55. Tuesday (Oct 6) delivers US trade data, followed by the EIA weekly crude inventories on Wednesday (Oct 7). For a discretionary-facing name in movies and entertainment, the services activity readings are the ones to watch.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.